Gaithersburg, MD, United States of America

Carmen J Allegra

This inventor holds 4 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, The United States of America as Represented by the Secretary of, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1987-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carmen J Allegra. Retrieved from https://idiyas.com/inventor/carmen-j-allegra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 32(Granted Patents)


Location History:

  • Vienna, VA (US) (1987)
  • North Potomac, MD (US) (1999)
  • Gaithersburg, MD (US) (1991 - 2001)

Company Filing History:


Years Active: 1987-2001

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Carmen J Allegra

Introduction

Carmen J Allegra, an accomplished inventor based in Gaithersburg, MD, has made significant strides in the field of biotechnology. With a portfolio of 4 patents, her work primarily focuses on the development of monoclonal antibodies and methods for enhancing cancer treatment. Her contributions are not only valuable for scientific research but also carry the potential for real-world clinical applications.

Latest Patents

One of Allegra's notable inventions is related to monoclonal antibodies specific for human thymidylate synthase. This invention encompasses the production of hybridomas that produce these specific antibodies and introduces methods for detection, alongside diagnostic kits to test for the presence of thymidylate synthase. Additionally, these antibodies hold promise in determining the presence of colon carcinoma cells, which could lead to better diagnostic and treatment methods.

Another critical patent focuses on methods for predicting the efficacy of a chemotherapeutic regimen for patients afflicted with gastrointestinal cancers. This innovative approach provides crucial insights into whether specific chemotherapeutic treatments are suitable for individual patients, highlighting the importance of personalized medicine in oncology.

Career Highlights

Throughout her career, Carmen J Allegra has worked closely with the United States Department of Health and Human Services, contributing her expertise to the advancement of public health. Her work reflects a commitment to not only advancing medical science but also ensuring that her discoveries translate into tangible benefits for patients.

Collaborations

Allegra's innovative journey has been enriched through collaborations with esteemed professionals such as Patrick G Johnston and Bruce A Chabner. These partnerships have fostered an environment of shared knowledge and expertise, enhancing the impact of her inventions on the scientific community.

Conclusion

Carmen J Allegra's dedication to innovation in biotechnology is evident through her patented inventions and collaborations. Her work in developing diagnostic tools and methods for improving cancer treatments positions her as a significant contributor to the field of medical research. As she continues to explore new ideas and technologies, Allegra's innovations promise to leave a lasting impact on cancer care and patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…